布局“环保+生物医药”赛道 跨界融合启新程

Core Viewpoint - Liu Yang, a seasoned entrepreneur in the biopharmaceutical sector, has acquired a controlling stake in Zhongfu Technology (formerly Zhonghuan Environmental Protection) for 598 million yuan, marking a strategic shift towards integrating environmental protection with biopharmaceuticals [1][2]. Group 1: Strategic Intent - The acquisition is described as a strategic exploration rather than mere capital arbitrage, aiming to build a biopharmaceutical ecosystem while leveraging the existing environmental business [1][2]. - Liu Yang emphasizes the importance of a dual-track strategy, combining environmental protection and biopharmaceuticals to drive growth and innovation [2][3]. Group 2: Business Integration - The existing environmental business will not be replaced but upgraded, focusing on management optimization and operational efficiency to ensure stable cash flow and shareholder returns [2][3]. - A new subsidiary, Dingfu Pharmaceutical, has been established to implement the biopharmaceutical strategy, focusing on innovative projects with global commercialization potential [2][3]. Group 3: Capital Operations - The company is preparing for a targeted capital increase to strengthen control and support the new business layout, leveraging the advantages of being a publicly listed company [3]. - The recent rebranding from "Zhonghuan Environmental Protection" to "Zhongfu Technology" reflects the commitment to the biopharmaceutical sector and strategic transformation [3][4]. Group 4: Future Goals - Liu Yang outlines a clear plan for the next 3-5 years, aiming to enhance the quality and efficiency of the environmental business while accelerating the industrialization of the biopharmaceutical sector [3][4]. - The goal is to transform Zhongfu Technology into a comprehensive technology platform that spans green economy and life sciences, contributing to high-quality industrial development [5].